Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The COMBAT Project: study protocol for the development of a core outcome set for morbidity following surgery in paediatric brain tumour patients.

Trials·2025
Same author

Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials.

Pediatric blood & cancer·2023
Same author

Bilateral Permanent Childhood Hearing Loss and Health-Related Quality of Life in Adolescence.

Children (Basel, Switzerland)·2021
Same author

Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 study.

Journal of neurosurgery. Pediatrics·2020
Same author

Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives.

BMJ paediatrics open·2020
Same author

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Neuro-oncology practice·2019
Same journal

Not all acute peripheral facial palsy in children recovers completely: A telediagnostic follow-up study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same journal

The prevalence of spinal muscular atrophy in Kazakhstan and the experience with the national nusinersen treatment program.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same journal

Motor-free visual perception and visuomotor integration in pediatric arterial ischemic stroke.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same journal

Familial, recurrent or genetic acute necrotizing encephalopathy of childhood: a systematic review and a case report. Focus on atypical events and on the role on immunizations.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same journal

Cenobamate in pediatric epilepsy: Moving beyond anecdotal experience.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same journal

Re: Diodato et al. "Distal arthrogryposis with impaired proprioception and touch: description of 9 additional cases harbouring novel PIEZO2 variants and literature review" (European Journal of Paediatric Neurology 61, 2026, 24-35).

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood

Published on: January 9, 2018

Refining immunotherapy for NMDAR encephalitis

Colin Kennedy

    European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
    |September 30, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
    10:50

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

    Published on: March 26, 2019

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Related Experiment Videos

    Last Updated: May 29, 2026

    A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
    07:20

    A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood

    Published on: January 9, 2018

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
    10:50

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

    Published on: March 26, 2019

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016